Thanks for the efforts of our distributors all over the world. Although COVID-19 crushes the world economy, BiOptic is still growing while facing this pandemic. Due to the increasing number of orders, our production efficiency almost reaches its limit, so we decided to enlarge the space of our production line to fulfill the market demand. The headquarter of BiOptic Inc. will be relocated to the next building beside our existing ones from 12/19 to 12/20.
The consequences of the coronavirus disease (COVID-19) outbreak are unprecedented and felt around the world. Industries are being profoundly affected by the pandemic. Fortunately, BiOptic Inc. remains high productivity and keeps devoted to technological innovation. The outstanding R&D capabilities allow us to win several Technology Development Program (TDP) from the government and were favored by the committee of Taipei Biotech Awards – Innovation Award in July 2020.
BiOptic Inc. won A+ Industrial Innovation R&D Program
2020-11-13
The winner of A+ Industrial Innovation R&D Program has been announced a few days ago. Based on our breakthrough technology and R&D Vision and Directions, BiOptic Inc. was finally selected by the committee and received the subsidies after several rounds of competition between many outstanding manufacturers throughout the world. Perhaps, the growing market share of BiOptic's products in over 50 countries might also be part of the winning factors.
SPECIAL ANNOUNCEMENT
For gathering every distributor/partner around the world together and letting BiOptic to share more information about our new products and functions under the threat of COVID-19, BiOptic will have our 2020 distributor meeting as a Web Conference!
【BiOptic X Global Bio& Investment Science Detection Project】
2020-09-14
September 21th is International Dementia Day, which is formulated by Alzheimer's Disease International (ADI). The purpose is to let more and more people realize this disease, care about the patients and their families. To respond to this meaningful day, BiOptic and Global Bio& Investment hold a science project to make more people this disease deeply.
